1. Introduction {#sec1}
===============

Tyrosinase (TYR) belongs to the type 3 copper protein family containing dinuclear copper ions and widely exists in nature from microorganisms to humans \[[@B1]\]. It is a critical enzyme in the synthesis process of melanin pigments, catalyzing orthohydroxylation of monophenols to *o*-diphenols and then to the corresponding *o*-quinones \[[@B2]\]. However, overproduction of melanin pigments becomes a problem in the cosmetic and clinical points of view, such as melasma, freckles, and melanosis \[[@B3], [@B4]\]. Due to the importance of TYR during the synthesis of melanin, blocking the activity of TYR is one of the ideal strategies to treat melanin pigment diseases currently. To date, arbutin and kojic acid are the most commonly used tyrosinase inhibitors, which often serve as positive control drugs \[[@B5], [@B6]\]. However, traditional synthetic or microbial origin tyrosine inhibitors have some drawbacks, such as long-term contact of hydroquinone can lead to skin cancer, dermatitis, and other diseases \[[@B7], [@B8]\]. In reality, it is reported that the polyphenols and flavonoids isolated from natural plants have significant tyrosinase inhibition effect and less potential side effects \[[@B9], [@B10]\]. From this point of view, it is of great importance to screen TYR inhibitors from natural products.

Salviae Miltiorrhizae Radix et Rhizoma (Danshen in Chinese, DS) is the dried root or rhizome of *Salvia miltiorrhiza* Bunge, in which the main components are phenolic acids and diterpenes \[[@B11]\]. *Carthami flos* (Honghua in Chinese, HH), the dried flower of *Carthamus tinctorius* L., is generally composed of flavonoids, fatty acids, volatile oils, and polysaccharides \[[@B12]\]. In previous reports, the inhibitory effect of *Salvia miltiorrhiza* and *Carthamus tinctorius* on tyrosinase has been validated \[[@B13]--[@B15]\]; however, the active constituents with tyrosinase inhibition activity have not been clearly reported yet. Therefore, in this study, a spectrum-effect analysis method is developed to screen the active constituents that inhibit tyrosinase in Danshen--Honghua (DH) herbal pair. The spectrum-effect relationship analysis combines the chemical compositions of the fingerprint of natural products with the results of the efficacy, and is originally used to develop control standards that can truly reflect the inherent quality of products \[[@B16]\]. Furthermore, spectrum-effect analysis is also used to screen the active components from natural products \[[@B17]\]. In reality, spectrum-effect analysis shows some positive features such as reliability, time-saving capacity, and simple operation \[[@B18], [@B19]\].

In this study, the inhibition effect of DH herbal pair and single drug on tyrosinase was compared first. Then, the components in the DH herbal pair are analyzed and identified by HPLC analysis. Third, the active components in DH herbal pair were predicted by spectrum-effect analysis, and their structures were identified by LC-MS analysis. Furthermore, the TYR inhibition activities of the predicted compounds were evaluated in an *in vitro* model. Finally, molecular docking, which is a method of drug design through the characterization of the receptor and the interaction between the receptor and the drug molecules, and binding mode and affinity prediction \[[@B20]\], was used to confirm the binding sites of compounds with tyrosinase and to predict several possible TYR inhibitors which possess similar structure to the screened active compounds by molecular docking.

2. Materials and Methods {#sec2}
========================

2.1. Chemicals and Materials {#sec2.1}
----------------------------

Tyrosinase (MW 128 kDa) from *Agaricus bisporus*, kojic acid (≥98%), and L-tyrosine were purchased from Sigma-Aldrich (St. Louis, MO, USA). Tyrosinase, kojic acid, and L-tyrosine were dissolved in 50 mM sodium phosphate buffer (pH 6.8) before use. The reference compounds protocatechuic aldehyde, hydroxysafflor yellow A, tanshinone IIA, lithospermic acid, and salvianolic acid A (≥98%, determined by HPLC) were obtained from PUSH Bio-Technology Co., Ltd. (Chengdu, China). HPLC-grade acetonitrile and formic acid were obtained from Beijing InnoChem Science & Technology Co., Ltd. (Beijing, China). All of the experimental water was purified by water purification system (ATSelem 1820A, Antesheng Environmental Protection Equipment Co., Ltd., Chongqing, China). All other chemicals and solvents, unless otherwise specified, were guaranteed reagent grade and purchased from Sigma-Aldrich Chemical Co. LLC. (St. Louis, MO, USA).

Crude drugs of Danshen and Honghua were both purchased from Chongqing Heping Pharmacy Co., Ltd. (Chongqing, China), in June 2017. The voucher specimens of *Salvia miltiorrhiza* Bunge (number SM2017090101) and *Carthamus tinctorius* L. (number CF2017090101) were deposited at the Pharmaceutical Engineering Laboratory in School of Chemistry and Chemical Engineering, Chongqing University, Chongqing, China.

2.2. Preparation of DH Extracts and Stock Solutions {#sec2.2}
---------------------------------------------------

All the dried raw DS and HH were pulverized and griddled through 50 mesh sieves (about 0.29 mm) prior to extraction. Seven different proportions of the herbs were prepared with ratios of 1 : 1, 2 : 1, 3 : 1, 5 : 1, 1 : 5, 1 : 3, and 1 : 2 (g/g) DS to HH, respectively. 20 g of DS and HH mixed powder was extracted with 200 mL water in a glass-stoppered conical flask at 75°C for 1.5 h. After extraction, the mixture was filtered through gauze, and the residue was collected and extracted with the above process for a second time. The two filtrates were combined and evaporated in a rotary evaporator (ZFQ 85A, Shanghai Medical Instrument Special Factory, Shanghai, China) at 55°C under reducing pressure to remove the solvent. The extracts were further dried by lyophilization with freezing-drying system (DZF-6050, Shanghai Jing Hong Laboratory Instrument Co., Ltd., Shanghai, China) to obtain the DH extracts at a yield of about 25% (w/w, dried extract/crude herb). All pre- and postdilution solutions were stored at 4°C. Before HPLC analysis, the sample solutions were filtered through a 0.22 *μ*m nylon membrane filter (Shanghai Titan Scientific Co., Ltd., Shanghai, China).

The reference substances protocatechuic aldehyde, hydroxysafflor yellow A, tanshinone IIA, lithospermic acid, and salvianolic acid A and a positive control (kojic acid) were all prepared by dissolving the respective substance in methanol solution and diluted with PBS (50 mM, pH 6.8) to the required concentrations for TYR inhibitory and binding assay, respectively. All the solutions were stored at 4°C in dark before use.

2.3. HPLC and LC-MS Analysis {#sec2.3}
----------------------------

HPLC analysis was performed on an Agilent 1260 series liquid chromatograph system (Agilent Technologies, Palo Alto, CA, USA), which was equipped with a vacuum degasser, a binary pump, an autosampler, and a diode array detector (DAD), controlled by Agilent ChemStation software. An Agilent Zorbax SB-Aq column (250 mm × 4.6 mm, 5 *μ*m) preceded by a Zorbax SB-C~18~ guard column (12.5 × 4.6 mm, 5 *μ*m) was adopted for the analysis. The mobile phase consisted of solvent A (0.1% formic acid aqueous solution) and solvent B (acetonitrile) using a gradient elution, which was programmed as follows: 5% B at 0--2 min, 5%--15% B at 2--10 min, 15%--22% B at 10--24 min, 22%--29% B at 24--35 min, 29%--37% B at 35--42 min, and 37%--5% B at 42--47 min. The mobile phase was set at a flow rate of 1.0 mL/min with 10 *μ*L per sample injection. The UV detection wavelength was set at 280 nm, and the column temperature was conditioned at 37°C.

Shimadzu LC/MS-MS 8060 electrospray ionization-mass spectrometer (ESI-MS), consisting of a Triple Quadruple Detector (TSQ) as the mass detector (Shimadzu, Kyoto, Japan) and coupled with HPLC, was used for LC-MS identification. The LC conditions were the same as described previously. The ESI-MS conditions were as follows: the ESI was used in both positive and negative mode; nitrogen gas was used for desolvation at a flow rate of 3 L/min at 250°C; the temperature and flow rate of drying gas were set under 400°C and 10 L/min, respectively; the cone voltage was (+) 20 and (−) 20 V; MS data were recorded in the full-scan mode (*m/z* 50--1500), and MS^2^ data were recorded in the range of *m/z* 50--1200.

2.4. TYR Inhibitory Activity Assay {#sec2.4}
----------------------------------

The enzyme assay was performed in 96-well Corining Costar plates (Corning Incorporated, USA). 50 *μ*L test solution and 50 *μ*L TYR solution (800 U/mL) were mixed and incubated for 10 min at room temperature. After the incubation, 100 *μ*L (1 mg/mL) of L-tyrosine in PBS (pH 6.8) buffer as chromogenic substrate was added to start the reaction. The absorbance was monitored at 490 nm every 30 s for 10 min with an iMark™ Microplate Absorbance Reader (Bio-Rad Laboratories, Inc., USA). PBS (50 mM, pH 6.8) buffer was prepared as blank control, and kojic acid was used as positive control. TYR inhibition activity was expressed as the inhibitory percentage of TYR:$$\begin{matrix}
{\text{Inhibition  percentage  }\left( \% \right) = \frac{\left( {dA/{dt}} \right)_{\text{blank}} - \left( {dA/{dt}} \right)_{\text{sample}}}{\left( {dA/{dt}} \right)_{\text{blank}}} \times 100\%,} \\
\end{matrix}$$where(*dA*/*dt*)~blank~ and (*dA*/*dt*)~sample~ are the reaction rate of the blank and sample group, respectively. All trials were independently performed in triplicates, and the results were shown with mean value of the triplicate observations.

2.5. Spectrum-Effect Relationship Analysis {#sec2.5}
------------------------------------------

Spectrum-effect analysis was performed by transferring DH fingerprint peak area and TYR inhibition activity test results into SPSS software for canonical correlation analysis (CCA). The optimized HPLC fingerprints of seven ratios DH samples were calculated and generated by professional software named "Similarity Evaluation System for Chromatographic Fingerprint of Traditional Chinese Medicine" composed by Chinese Pharmacopoeia Committee (Version 2012). CCA was used to assess the spectrum-effect relationships between the areas of 86 peaks in fingerprint and the TYR inhibition ratios.

2.6. In Silico Molecular Docking of TYR and Identified Active Compounds {#sec2.6}
-----------------------------------------------------------------------

Auto Dock 4.2 program (The Scripps Research Institute, La Jolla, CA, USA) was employed for *in silico* molecular docking study to validate the binding potency of the compounds to TYR \[[@B21]\]. The docking operation was performed according to the following steps. First, the crystal structure file of TYR (*Agaricus bisporus* mushroom tyrosinase) complex (PDB ID = 2y9x) was downloaded \[[@B22]\]. The dimension grid box (90 Å × 90 Å × 102 Å) and the grid spacing of 0.619 Å were defined to enclose the active site. Second, the ligand was deleted using UCSF Chimera, and unnecessary water molecules were removed, and hydrogen atoms were added \[[@B23]\]. Third, the 3D chemical structure of investigated compounds was drawn by using Microsoft office 3D and output in PDB format with minimized energy.

With the aim of docking with Autodock Vina, the grid size was set to (*x*, *y*, *z*) = (50, 50, 50) and the grid center was set to (*x*, *y*, *z*) = (10.044, 28.706, 43.443). In each simulation process, progress with default parameters run from Autogrid and Autodock. Lamarckian genetic algorithm (LGA) was used to find the most favorable ligand binding orientations, and the number of LGA runs is equal to 50. The interaction figures were generated, and the results of docking were recorded with binding energies and bonded residues.

2.7. Statistical Analysis {#sec2.7}
-------------------------

All data are presented as mean ±standard deviations (SD) of at least three different experiments. The statistical analysis was performed with SPSS (version 24, SPSS, Inc., Chicago, IL, USA).

3. Results and Discussion {#sec3}
=========================

3.1. Effects of DH Extracts on Tyrosinase Activity {#sec3.1}
--------------------------------------------------

As shown in [Table 1](#tab1){ref-type="table"} and [Figure 1](#fig1){ref-type="fig"}, PBS served as a blank control, while kojic acid served as a positive control. Some DH herbal pair extracts (1 : 5 and 1 : 3) showed a weaker inhibitory effect than single herbal extracts when the concentrations of tyrosinase and the sample were kept constant. However, other DH herbal pair extracts (1 : 1, 3 : 1, 5 : 1, and 1 : 2) displayed a stronger inhibitory effect than single herbal extracts, which indicated that a synergistic effect of the herbal pair may occur on the inhibition of tyrosinase activity. Therefore, DH herbal pair was used as the research object for screening their tyrosinase inhibitors.

In order to obtain the best screening performance for active compounds in the complex matrix, some important parameters of the method including incubation time, TYR concentration, and sample concentration should be optimized. According to previous research, the incubation time might be controlled at the range of 30--120 min because a short incubation time (less than 30 min) might prevent the identification of target molecules which are not firmly bound to TYR, while a long incubation time (about 120 minutes) would not make significant influence on the screening result \[[@B24], [@B25]\]. After investigation, a proper TYR concentration (800 U/mL) increased the sensitivity and number of bioactive constituents detected in the sample; meanwhile, the inhibition effect of tyrosinase is most stable by the incubation time of 40 min (data not shown). Therefore, a sufficient incubation time (40 min) and a sufficient TYR concentration (800 U/mL) were used in this study.

3.2. Spectrum-Effect Relationship Analysis {#sec3.2}
------------------------------------------

The optimized HPLC fingerprints of DH samples with seven ratios are shown in [Figure 2](#fig2){ref-type="fig"}. A total of 86 peaks involved were detected in the calculation of spectrum-effect relationship. CCA (canonical correlation analysis) was used to assess the spectrum-effect relationship between the areas of 86 peaks and the main parameters (inhibition rate), and the results are shown in [Table 2](#tab2){ref-type="table"}. As suggested by the correlation coefficients, the highly relevant peaks were 1, 8, 13, 15, 20, 22, 27, 29, 31, 36, 40, 44, 46, 54, 55, 64, and 74 with Pearson relational grade more than 0.8. In other words, these 17 peaks might be the main active components of herbal pair for inhibiting tyrosinase, and further studies were performed to identify the structures of these peaks to confirm their bioactivities.

3.3. Identification of the Potential TYR-Targeted Compound by LC-MS Analysis {#sec3.3}
----------------------------------------------------------------------------

HPLC-MS/MS analysis was used to identify the chemical structures of compounds in DH extracts. Based on the fragmentation behaviors, retention time and MS data ([Table 3](#tab3){ref-type="table"}) of the peaks in the test samples, 13 compounds (protocatechuic aldehyde, danshensu, phenylalanine, tanshinone IIA, caffeic acid, 6-hydroxykaempferol-3,6,7-*O*-*β*-D-glucoside, hydroxysafflor yellow A, rosmarinic acid, anhydrosafflor yellow B, 6-hydroxykaempferol 3-*O*-rutinoside-6-*O*-glucoside, lithospermic acid, salvianolic acid A, and salvianolic acid E) were tentatively identified, and the structures of these compounds are shown in [Figure 3](#fig3){ref-type="fig"}. Five pure reference compounds including protocatechuic aldehyde, tanshinone IIA, hydroxysafflor yellow A, lithospermic acid, and salvianolic acid A were obtained for further *in vitro* activity tests.

3.4. In Vitro Activity Tests for the Predicted Compounds {#sec3.4}
--------------------------------------------------------

To confirm the ability of the hit compounds with TYR inhibitory activity, *in vitro* enzymatic activity assays were performed. Five concentrations of each compound were tested, and the results are shown in [Table 4](#tab4){ref-type="table"}. As a well-known TYR inhibitor \[[@B5]\], kojic acid showed strong inhibition effect with a IC50 value of 127 *μ*M. From the results shown in [Figure 4](#fig4){ref-type="fig"}, among the five identified hit compounds, protocatechuic aldehyde, hydroxysafflor yellow A, and tanshinone IIA possessed strong TYR inhibition effects in a dose-dependent manner, with the IC50 values of 455, 498, and 1214 *μ*M, respectively. However, lithospermic acid and salvianolic acid A did not show significant inhibitory effect on tyrosinase at a relatively high concentration (1.6 mM). The reason may be that they do not combine with the active amino acid residues or do not act on the active center of TYR, but further studies are required.

3.5. Molecular Docking of TYR and Identified Active Compounds {#sec3.5}
-------------------------------------------------------------

Molecular docking can be used to study the binding mechanism of compounds interacting with proteins. In this study, Autodock 4.2 was selected as the docking software to check out the active site of those components screened from DH extracts combined with TYR. The crystal structure of tyrosinase includes four identical parts, and one of them was used as the crystal structure of tyrosinase for computational docking analysis. Interestingly, as shown in Figures [5(a)](#fig5){ref-type="fig"} and [5(b)](#fig5){ref-type="fig"}, protocatechuic aldehyde and hydroxysafflor yellow A could bond to the same catalytically active amino acid residues (THR324, ASN81, CYS83, GLU322, and HIS85) of TYR, which could explain the similar TYR inhibitory activity of these two compounds. Moreover, three hydrogen bonds (green line) between protocatechuic aldehyde, hydroxysafflor yellow A, and the amino acid residues were observed. As shown in [Figure 5(c)](#fig5){ref-type="fig"}, tanshinone IIA was found bonding into the hydrophobic cavity of tyrosinase (blue region) and surrounded by amino acid residues VAL248, HIS244, OTR410, VAL283, SER282, PRO277, PHE264, and ARG268 of tyrosinase. The amino acid residues of the tyrosinase to which the active compound binds are shown in [Table 5](#tab5){ref-type="table"}. The reason for the weak activity may be that lithospermic acid and salvianolic acid A do not combine with the active amino acid residues (such as GLU322 and THR324) or do not act on the active center (Cu^2+^) of tyrosinase. As tyrosinase is a copper-containing enzyme, it is expected that potential tyrosinase inhibitors should show high binding affinity for copper ions \[[@B26]\].

Along with the screening result, molecular docking was also carried out on compounds (absence of pure reference substances) having similar structure to protocatechuic aldehyde, lithospermic acid, and salvianolic acid A (the structure of these compounds are shown in [Figure 4](#fig4){ref-type="fig"}), attempting to explore other active TYR inhibitors by perspective of structure-activity relationship. As shown in [Figure 5(a)](#fig5){ref-type="fig"}, the important region of protocatechuic aldehyde for copper chelation was the catechol structure. Compounds that functionally chelate copper ions at tyrosinase active sites have been frequently reported as effective tyrosinase inhibitors because they are analogous to the phenolic hydroxyl substrates of tyrosinase \[[@B27], [@B28]\]. In addition, danshensu, caffeic acid, rosmarinic acid, and salvianolic acid E having a catechol structure might also be potential TYR inhibitors. The docking result is shown in [Table 5](#tab5){ref-type="table"}. With a portion of the same active sites with screened active compounds bound to TYR, it could be found that danshensu, caffeic acid, rosmarinic acid, salvianolic acid E, anhydrosafflor yellow B, 6-hydroxykaempferol-3,6,7-O-*β*-D-glucoside, and 6-hydroxykaempferol 3-*O*-rutinoside-6-*O*-glucoside similar to protocatechuic aldehyde, hydroxysafflor yellow A, and tanshinone IIA might also be potential TYR inhibitors. However, pure substances of these compounds were required for the further activity tests.

4. Conclusions {#sec4}
==============

In this study, the TYR inhibitor screening methods were established, and the potential TYR inhibitory components from DH extract were screened. Combining the results of spectrum-effect analysis, LC-MS analysis, and enzymatic activity assay, three active compounds including protocatechuic aldehyde, hydroxysafflor yellow A, and tanshinone IIA were discovered as inhibitors targeting TYR. Meanwhile, docking results showed that these compounds might bind to the same amino acid residues in TYR catalytic pocket. Additionally, other potential active TYR inhibitors such as danshensu, caffeic acid, rosmarinic acid, and salvianolic acid E, which gained similar structures with the hit compounds, might also be identified. These results proved that the proposed method could effectively screen TYR inhibitors in complex mixtures and provided a reference for the discovery of other active TYR inhibitors.
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![Different ratios of DH herbal pair on tyrosinase inhibition effects.](JAMC2018-2141389.001){#fig1}

![HPLC calibration fingerprints of DH herbal pair with different ratios. The chromatograms of S1--S7 are represented as follows: DH 1 : 1 (S1); DH 2 : 1 (S2); DH 3 : 1 (S3); DH 5 : 1 (S4); DH 1 : 5 (S5); DH 1 : 3 (S6); DH 1 : 2 (S7); control map (R).](JAMC2018-2141389.002){#fig2}

![Chemical structures of compounds identified in DH herbal pair. The numbers of compounds are the same as the peak numbers in [Figure 2](#fig2){ref-type="fig"}.](JAMC2018-2141389.003){#fig3}

![Inhibitory rate of active components to tyrosinase with different concentrations.](JAMC2018-2141389.004){#fig4}

![Molecular docking results of protocatechuic aldehyde (a), hydroxysafflor yellow A (b), and tanshinone IIA (c) with tyrosinase.](JAMC2018-2141389.005){#fig5}

###### 

Inhibition effect of DH extracts on tyrosinase with different ratios (*n* = 9).

  Sample          Inhibition rate (%)
  --------------- ---------------------
  Blank^a^        0.06 ± 0.01
  Kojic acid^b^   76.83 ± 0.24
  DH 1 : 0^b^     26.55 ± 0.17
  DH 0 : 1^b^     34.70 ± 0.98
  DH 1 : 1^b^     42.19 ± 0.10
  DH 2 : 1^b^     29.93 ± 0.32
  DH 3 : 1^b^     40.53 ± 0.28
  DH 5 : 1^b^     46.84 ± 0.30
  DH 1 : 5^b^     16.15 ± 1.05
  DH 1 : 3^b^     25.72 ± 0.17
  DH 1 : 2^b^     38.90 ± 0.09

^a^Concentration: PBS (50 mM, pH6.8); ^b^concentration: 500 *μ*g/mL.

###### 

Correlation coefficients between chromatogram peaks and inhibition rates.

  ----------------- ---------- ----------- ----------- -------- ----------- -------- ---------- ---------- ---------- ----------- -------- ---------- ----------
  Peak number       1          2           3           4        5           6        7          8          9          10          11       12         13
  Inhibition rate   0.940^∗^   −0.702      −0.695      −0.501   −0.753      −0.769   −0.677     0.812^∗^   −0.721     −0.775      −0.790   −0.351     0.807^∗^
  Peak number       **14**     **15**      **16**      **17**   **18**      **19**   **20**     **21**     **22**     **23**      **24**   **25**     **26**
  Inhibition rate   0.510      −0.878^∗^   −0.742      −0.632   −0.713      0.714    0.919^∗^   −0.746     0.903^∗^   −0.129      −0.615   −0.233     −0.623
  Peak number       27         28          29          30       31          32       33         34         35         36          37       38         39
  Inhibition rate   0.952^∗^   −0.544      0.908^∗^    0.650    0.900^∗^    −0.397   −0.015     −0.466     0.321      −0.824^∗^   −0.795   −0.726     −0.762
  Peak number       **40**     **41**      **42**      **43**   **44**      **45**   **46**     **47**     **48**     **49**      **50**   **51**     **52**
  Inhibition rate   0.892^∗^   −0.571      −0.790      −0.785   −0.867^∗^   −0.745   0.891^∗^   −0.640     −0.746     −0.708      0.135    −0.753     −0.451
  Peak number       **53**     **54**      **55**      **56**   **57**      **58**   **59**     **60**     **61**     **62**      **63**   **64**     **65**
  Inhibition rate   −0.627     −0.943^∗^   −0.929^∗^   −0.759   −0.778      −0.037   −0.769     0.591      −0.621     −0.741      0.786    0.824^∗^   −0.725
  Peak number       **66**     **67**      **68**      **69**   **70**      **71**   **72**     **73**     **74**     **75**      **76**   **77**     **78**
  Inhibition rate   −0.667     −0.772      0.596       0.618    0.124       0.704    −0.712     0.654      0.887^∗^   0.215       0.361    0.371      0.718
  Peak number       **79**     **80**      **81**      **82**   **83**      **84**   **85**     **86**                                                 
  Inhibition rate   0.610      0.646       −0.733      0.565    −0.717      0.279    −0.123     −0.512                                                 
  ----------------- ---------- ----------- ----------- -------- ----------- -------- ---------- ---------- ---------- ----------- -------- ---------- ----------

*Note*. Pearson correlation, "r" represents the relevant strength; ^∗^0.8 ≤ \|*r*\| ≤ 1 means Very significant correlation.

###### 

HPLC-MS/MS data of 17 predicted active compounds from DH herbal pair.

  Peak No.   *t* ~R~ (min)   MW     MS^1^ (*m/z*)   MS^2^ (*m/z*)                       Formula           Structural identification
  ---------- --------------- ------ --------------- ----------------------------------- ----------------- ------------------------------------------------------
  **1**      3.087           138    138.05          92; 78; 65                          C~7~H~6~O~3~      Protocatechuic aldehyde
  **8**      3.112           198    197.05          178                                 C~9~H~10~O~5~     Danshensu
  **13**     6.491           165    166.09          120                                 C~9~H~11~NO~2~    Phenylalanine
  **15**     7.108           ---    ---             ---                                 ---               Unknown
  **20**     7.952           294    295.15          277; 249                            C~19~H~18~O~3~    Tanshinone IIA
  **22**     8.951           180    179.10          135                                 C~9~H~8~O~4~      Caffeic acid
  **27**     11.207          ---    ---             ---                                 ---               Unknown
  **29**     12.386          788    787.40          625; 505; 463; 301                  C~33~H~40~O~22~   6-Hydroxykaempferol-3,6,7-*O*-*β*-D-glucoside
  **31**     12.771          612    611.30          491; 473; 403; 353; 325; 283; 205   C~27~H~32~O~16~   Hydroxysafflor yellow A
  **36**     14.094          640    639.30          463; 362; 300; 255; 139             ---               Unknown
  **40**     17.091          772    773.35          695; 672; 303; 187; 112             C~33~H~40~O~21~   6-Hydroxykaempferol 3-*O*-rutinoside-6-*O*-glucoside
  **44**     21.352          ---    ---             ---                                 ---               Unknown
  **46**     23.969          1044   1043.45         1025; 923; 863; 764; 593; 449       C~48~H~52~O~26~   Anhydrosafflor yellow B
  **54**     29.882          360    359.25          179; 161; 133                       C~18~H~16~O~8~    Rosmarinic acid
  **55**     31.813          538    537.25          295; 253; 203                       C~27~H~22~O~12~   Lithospermic acid
  **64**     32.528          494    493.25          295                                 C~26~H~22~O~10~   Salvianolic acid A
  **74**     36.747          718    717.35          673; 617; 519; 321                  ---               Salvianolic acid E

###### 

Inhibition effect of protocatechuic aldehyde, tanshinone IIA, hydroxysafflor yellow A, lithospermic acid, and salvianolic acid A on tyrosinase (*n*=9).

  Compounds                 Concentration (mmol)   Inhibition rate (%)
  ------------------------- ---------------------- ---------------------
  Blank                     PBS (50 mM, pH 6.8)    0.44 ± 0.02
                                                   
  Kojic acid                1.6                    88.93 ± 0.28
  0.8                       85.97 ± 0.45           
  0.4                       76.63 ± 1.02           
  0.2                       63.97 ± 2.11           
  0.1                       40.72 ± 0.15           
                                                   
  Protocatechuic aldehyde   1.6                    80.18 ± 0.08
  0.8                       69.91 ± 2.97           
  0.4                       49.80 ± 1.30           
  0.2                       21.29 ± 1.01           
  0.1                       13.78 ± 0.95           
                                                   
  Tanshinone IIA            1.6                    57.88 ± 1.98
  0.8                       37.26 ± 2.87           
  0.4                       18.23 ± 2.23           
  0.2                       6.03 ± 1.12            
  0.1                       1.98 ± 0.05            
                                                   
  Hydroxysafflor yellow A   1.6                    62.48 ± 1.34
  0.8                       60.22 ± 2.28           
  0.4                       55.85 ± 1.80           
  0.2                       39.23 ± 1.12           
  0.1                       14.58 ± 0.55           
                                                   
  Lithospermic acid         1.6                    26.09 ± 3.28
  0.8                       19.62 ± 2.22           
  0.4                       11.52 ± 2.64           
  0.2                       7.28 ± 1.01            
  0.1                       4.32 ± 0.21            
                                                   
  Salvianolic acid A        1.6                    17.74 ± 3.06
  0.8                       14.42 ± 1.14           
  0.4                       8.25 ± 1.98            
  0.2                       5.04 ± 0.91            
  0.1                       1.25 ± 1.32            

###### 

Binding residues of identified compounds in DH herbal pair with tyrosinase.

  Compound                                               Residues                                                                                                                   Residues with hydrogen bonding
  ------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
  Kojic acid                                             ASN81, GLU322, CYS83, THR324, THR84, and HIS85                                                                             ASN81, CYS83, and HIS85
                                                                                                                                                                                    
  Protocatechuic aldehyde                                THR324, ASN81, CYS83, GLU322, and HIS85                                                                                    ASN81, CYS83, and HIS85
                                                                                                                                                                                    
  Hydroxysafflor yellow A                                THR324, ASN81, CYS83, GLU322, HIS85, PRO284, VAL283, SER282, GLY281, OTR410, and HIS244                                    ASN81, CYS83, HIS85, and HIS244
                                                                                                                                                                                    
  Tanshinone IIA                                         VAL248, HIS244, OTR410, VAL283, SER282, PRO277, PHE264, and ARG268                                                         VAL283 and SER282
                                                                                                                                                                                    
  Lithospermic acid                                      PRO270, THR261, GLY281, ARG268, PHE264, ASN260, MET257, SER282, VAL283, OTR410, VAL248, and HIS244                         GLY281, ARG268, PHE264, SER282, and VAL283
                                                                                                                                                                                    
  Salvianolic acid A                                     ASN81, CYS83, HIS85, VAL283, SER282, OTR410, HIS244, VAL248, PHE264, and ARG268                                            CYS83, HIS85, VAL283, SER282, and HIS244
                                                                                                                                                                                    
  Caffeic acid                                           PHE264, ARG268, OTR410, GLY281, VAL283, and SER282                                                                         PHE264, ARG268, VAL283, and SER282
                                                                                                                                                                                    
  Danshensu                                              PHE264, ARG268, OTR410, GLY281, VAL283, and SER282                                                                         ARG268, VAL283, and SER282
                                                                                                                                                                                    
  Phenylalanine                                          HIS244, HIS85, THR84, CYS83, GLU322, VAL283, and ASN81                                                                     HIS85, THR84, and GLU322
                                                                                                                                                                                    
  Rosmarinic acid                                        ARG268, PHE264, VAL248, HIS244, GLU322, OTR410, HIS85, SER282, and VAL283                                                  ARG268, GLU322, SER282, and VAL283
                                                                                                                                                                                    
  Salvianolic acid E                                     ARG268, PHE264, VAL248, HIS244, HIS85, SER282, VAL283, OTR410, and PRO284                                                  ARG268, SER282, VAL283, and HIS244
                                                                                                                                                                                    
  Anhydrosafflor yellow B                                GLU322, HIS244, HIS85, VAL248, VAL283, PRO284, ASN81, OTR410, ASN260, SER282, GLY281, PHE264, THR261, ARG268, and PRO277   GLY281 and ARG268
                                                                                                                                                                                    
  6-Hydroxykaempferol-3,6,7-*O*-*β*-D-glucoside          THR324, GLU322, ASN81, HIS85, HIS244, OTR410, VAL283, PRO284, GLY281, and SER282                                           GLU322, ASN81, HIS85, and HIS244
                                                                                                                                                                                    
  6-Hydroxykaempferol 3-*O*-rutinoside-6-*O*-glucoside   THR324, ASN81, HIS85, OTR410, VAL283, PRO284, GLY281, and SER282                                                           ASN81, HIS85, and GLY281

[^1]: Academic Editor: Jaroon Jakmunee
